Drug
Asp5541
Asp5541: highest development phase Phase 1, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| ASP5541 NCT07339267 | Phase 1 | Prostate Cancer |
Latest
No recent events.
Follow Asp5541 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.